A New Process for Small-Batch Purification of the Medical Isotope Molybdenum-99: Non-Technical Overview
Program Document
·
OSTI ID:1957726
- National Nuclear Security Administration (NNSA), Washington, DC (United States)
The U.S. medical community depends on a reliable supply of the radioisotope molybdenum-99 (Mo-99) for nuclear medical diagnostic procedures. Mo-99's decay product, technetium-99m (Tc-99m), is used in over 40,000 medical procedures in the United States each day to diagnose heart disease and cancer, to study organ structure and function, and to perform other important medical applications. For example, patients undergoing a common procedure—the cardiac “stress test”—likely have benefited from Tc-99m. Historically, Mo-99 was primarily produced through the fission of uranium-235, in the form of highly enriched uranium (HEU) targets irradiated in research and test reactors. HEU is a proliferation-sensitive material that, if diverted or stolen, could be used as a component of a nuclear weapon. NNSA’s Office of Material Management and Minimization (M3) manages the Molybdenum-99 (Mo-99) Program as part of its mission to minimize the use of HEU in civilian applications. The Mo-99 Program assists global Mo-99 production facilities in converting to non-HEU processes and supports the establishment of domestic supplies of Mo-99 without the use of proliferation-sensitive HEU. As part of this program, M3 funds U.S. national laboratories to provide non-proprietary technical support to U.S. companies working to establish non-HEU-based Mo-99 production capabilities. The results of this research are published on OSTI.gov for the benefit of the Mo-99 community and the public. However, it can be difficult for readers without a scientific background to understand and interpret these publications. In order to increase public understanding of the work being done in M3’s Mo-99 Program, this paper aims to provide an overview of a key, recent national laboratory technical publication in terms that can be understood by readers without a technical background. To accomplish this, the paper first explains key scientific concepts—primarily related to chemistry—that provide a foundation for understanding research in this area. This includes chromatography, absorption vs. adsorption, dissolution and precipitation, and liquid-liquid extraction. Drawing on these concepts, the paper then provides an explanation for non-technical audiences of the Argonne National Laboratory publication entitled Recovery of High Specific Activity Molybdenum-99 from Accelerator-Induced Fission on Low-Enriched Uranium for Technetium-99m Generators (Brown, M.A. et al., 2021) and related article Separation and Purification of Mo-99 Produced from Natural U3O8 Targets via Photo-Fission (Brown, M.A. et al., 2021).
- Research Organization:
- National Nuclear Security Administration (NNSA), Washington, DC (United States)
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- OSTI ID:
- 1957726
- Country of Publication:
- United States
- Language:
- English
Similar Records
Molybdenum-99 from Molten Salt Reactor as a Source of Technetium-99m for Nuclear Medicine: Past, Current, and Future of Molybdenum-99
Irradiation of 20L LEU Uranyl Sulfate Solution for Production of Mo-99
Mo-99 Concentration and processing by Solvent Extraction and Ion Exchange
Journal Article
·
Wed Feb 15 19:00:00 EST 2023
· Nuclear Technology
·
OSTI ID:1973362
Irradiation of 20L LEU Uranyl Sulfate Solution for Production of Mo-99
Technical Report
·
Thu Apr 01 00:00:00 EDT 2021
·
OSTI ID:1781392
Mo-99 Concentration and processing by Solvent Extraction and Ion Exchange
Technical Report
·
Fri Sep 01 00:00:00 EDT 2023
·
OSTI ID:2204216